What is FeelBetter?
Founded in 2018, FeelBetter operates at the intersection of healthcare and advanced analytics. The company provides a sophisticated medication management platform designed to optimize therapeutic outcomes and reduce the burden of polypharmacy. By integrating clinical data with machine learning algorithms, FeelBetter enables healthcare providers to make informed, real-time decisions, effectively bridging the gap between complex patient needs and standardized care protocols. Its market position is defined by its ability to scale within enterprise environments, offering a scalable solution that enhances patient safety while driving operational efficiency for health systems globally.
How much funding has FeelBetter raised?
FeelBetter has raised a total of $11.8M across 2 funding rounds:
Other Financing Round
$5.9M
Other Financing Round
$5.9M
Other Financing Round (2023): $5.9M with participation from Triventures, The Group Ventures, Random Forest VC, and Firstime Ventures
Other Financing Round (2023): $5.9M led by Firstime Ventures, Triventures, The Group Ventures, and Random Forest VC
Key Investors in FeelBetter
Triventures
Triventures is a global venture capital fund that invests in early-stage companies with innovative breakthroughs in healthcare and other industries, focusing on bio-convergence and data-driven technologies.
The Group Ventures
The Group Ventures is a funding and partnership firm that collaborates with exceptional tech ventures, focusing on B2B companies with strong differentiating technology and global scaling potential.
Random Forest VC
Random Forest VC is a boutique early-stage fund based in Israel that specializes in investing in AI and ML ventures, providing unique support through its in-house algorithm team.
What's next for FeelBetter?
Looking ahead, the infusion of capital will likely be directed toward scaling FeelBetter's core technology and expanding its footprint in international markets. The company is expected to prioritize the enhancement of its AI-driven diagnostic capabilities, further refining its predictive models to support personalized medicine initiatives. As FeelBetter transitions into its next phase of growth, strategic partnerships with global health organizations will be essential to achieving widespread adoption. The focus remains on maintaining a competitive edge through continuous innovation, ensuring that the platform remains an indispensable tool for clinicians navigating the complexities of modern medication management.
See full FeelBetter company page
